Beam Therapeutics BEAM Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's change in lease liabilities?
- Beam Therapeutics (BEAM) reported change in lease liabilities of -$3.49M in Q1 2026.
- How has Beam Therapeutics's change in lease liabilities changed year-over-year?
- Beam Therapeutics's change in lease liabilities decreased by 6.0% year-over-year, from -$3.3M to -$3.49M.
- What is the long-term trend for Beam Therapeutics's change in lease liabilities?
- Over 4 years (2021 to 2025), Beam Therapeutics's change in lease liabilities has grown at a -4.2% compound annual growth rate (CAGR), from $16.03M to -$13.51M.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.